Dexbrompheniramine/pseudoephedrine: Difference between revisions
tidy up advert into a neutral statement |
WhatamIdoing (talk | contribs) Rm spam |
||
| Line 33: | Line 33: | ||
As of 2008, Drixoral has been completely removed from the US market by manufacturer [[Merck & Co.|Merck]] (formerly Schering-Plough). The company's updated website attributes "changing [their] manufacturing location" for the supply disruption and currently states "it is unlikely product will be available in 2010".<ref>{{cite web|url=http://www.merck.com/product/usa/pi_circulars/d/drixoral.html|title=Products Currently Unavailable|accessdate=2010-05-18|date=2010|format=html|publisher=Merck}}</ref> However, the drug still appears to be available in Canada and overseas. |
As of 2008, Drixoral has been completely removed from the US market by manufacturer [[Merck & Co.|Merck]] (formerly Schering-Plough). The company's updated website attributes "changing [their] manufacturing location" for the supply disruption and currently states "it is unlikely product will be available in 2010".<ref>{{cite web|url=http://www.merck.com/product/usa/pi_circulars/d/drixoral.html|title=Products Currently Unavailable|accessdate=2010-05-18|date=2010|format=html|publisher=Merck}}</ref> However, the drug still appears to be available in Canada and overseas. |
||
<br /> |
|||
An Alabama-based pharmaceutical company, Poly Pharmaceuticals, markets the dexbrompheniramine maleate component under the name "Ala-hist IR".<ref>{{cite web |title=Win the War Against Seasonal Allergies |url=https://alahist.com |website=Poly Pharmaceuticals |accessdate=14 September 2019}}</ref> |
|||
==References== |
==References== |
||
Revision as of 22:50, 14 September 2019
| Combination of | |
|---|---|
| Dexbrompheniramine | Antihistamine |
| Pseudoephedrine | Decongestant |
| Clinical data | |
| Trade names | Drixoral |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code | |
| Legal status | |
| Legal status |
|
Dexbrompheniramine/pseudoephedrine (trade name Drixoral) is a combination medication that contains the antihistamine dexbrompheniramine maleate and the decongestant pseudoephedrine sulfate. It was manufactured by Schering-Plough and was used to treat symptoms associated with allergies and colds such as itchy and watery eyes, runny nose, nasal and sinus congestion, and sneezing. Because it contains pseudoephedrine, its purchase in the United States was severely restricted by the Combat Methamphetamine Epidemic Act of 2005 over fears that any product containing pseudoephedrine can be used to make methamphetamine.[1]
As of 2008, Drixoral has been completely removed from the US market by manufacturer Merck (formerly Schering-Plough). The company's updated website attributes "changing [their] manufacturing location" for the supply disruption and currently states "it is unlikely product will be available in 2010".[2] However, the drug still appears to be available in Canada and overseas.
References
- ^ Payne, January W. (March 9, 2009). "Drixoral: Why the Allergy Medicine Isn't Available, and What to Use Instead" (html). U.S. News and World Report. Retrieved 2010-02-22.
- ^ "Products Currently Unavailable" (html). Merck. 2010. Retrieved 2010-05-18.